background

The Aventiq Governance Framework™ & Continuous Intelligence™

Independent Technical Stewardship for India’s Life Sciences Ecosystem

Our Process

Continuous 6-Stage Governance & Lifecycle Optimization
Discover
01

Discover

Understand your program, goals and challenges.

Strategize
02

Strategize

Define the right development strategy and partner criteria.

Identify
03

Identify

Leverage our global network to identify the best-fit partners.

Evaluate
04

Evaluate

Conduct rigorous technical and regulatory evaluations.

Govern
05

Govern

Provide continuous oversight and program governance.

Succeed
06

Succeed

Drive execution excellence and accelerate commercialization.

COMPREHENSIVE LIFECYCLE GOVERNANCE

Aventiq Bio Oversight & Partner Facilitation Framework

Complete phase coverage and cross-cutting governance workstreams spanning discovery through commercial supply. We connect scientific workstreams, external partners, milestones and technical decisions across your entire program.

AVENTIQ BIO OVERSIGHT & PARTNER FACILITATION FRAMEWORK

DISCOVERY

Identify and validate novel targets and leads

  • Target identification
  • Hit-to-lead
  • In vitro / in silico studies
  • Early efficacy & safety screening

LEAD OPTIMISATION

Optimize and select clinical candidate

  • Lead optimization
  • Candidate selection
  • DMPK/ADME
  • Safety pharmacology
  • Preliminary toxicology

IND/CTA

Prepare and submit regulatory application

  • GLP toxicology studies
  • CMC documentation
  • Regulatory filings (IND/CTA)
  • Investigator's Brochure

CLINICAL DEVELOPMENT

Evaluate safety and efficacy in humans

  • Phase I – Safety/tolerability
  • Phase II – Dose finding efficacy
  • Phase III – Confirm efficacy and safety
  • Clinical operations support

REGULATORY

Regulatory review and market authorization

  • NDA/BLA/MAA submission
  • Health authority review
  • Labeling and risk management
  • Post-approval commitments

COMMERCIAL

Market access and lifecycle management

  • Launch and market access
  • Pharmacovigilance
  • Lifecycle management
  • Real-world evidence
  • Post-market studies

CORE OVERSIGHT & GOVERNANCE PILLARS (EXECUTED WITH TRUSTED CDMO & CRO PARTNERS)

CMC &
MANUFACTURING
Process development
Analytical development & validation
GMP manufacturing
(Drug substance & drug product)
Stability studies
Technology transfer & scale-up
REGULATORY &
QUALITY
Regulatory strategy and submissions
Global compliance
(US, EU, India, ROW)
GxP compliance
(GLP, GMP, GCP)
Quality systems and audits
Health authority interactions
TECHNICAL
GOVERNANCE
CRO/CDMO qualification
Vendor performance monitoring
Data integrity and risk management
Program oversight and governance
Alignment with development milestones
DETAILED OVERSIGHT SCOPE

Program Governance Coverage & Oversight Mandate

Detailed scope of how Aventiq Bio protects technical integrity, reduces execution risk, and enforces quality across each phase.

01

DISCOVERY & CANDIDATE SELECTION

Target → Hit → Lead → Candidate
Governance Coverage
Target & Assay Strategy Screening Hit Identification Hit-to-Lead Medicinal Chemistry DMPK/ADME Pharmacology
Aventiq helps assess whether external scientific partners, scopes and capabilities are aligned with program requirements.
02

PRECLINICAL & IND-ENABLING

Candidate → IND/CTA
Governance Coverage
PK/PD Safety Pharmacology GLP Toxicology Bioanalysis Formulation IND-Enabling Activities
Objective oversight helps identify technical, quality and cross-vendor dependencies before they affect regulatory milestones.
03

CLINICAL DEVELOPMENT

Phase I → Phase III
Governance Coverage
Clinical CROs Bioanalytical Strategy Clinical Supply Vendor Oversight Cross-Partner Governance
Aventiq provides an objective layer of technical visibility across outsourced development activities.
04

CMC & MANUFACTURING

Development → Scale-Up → GMP
Governance Coverage
Analytical Development Process Development Formulation Scale-Up Technology Transfer Validation GMP Manufacturing
Aventiq helps sponsors assess technical readiness, partner capability and execution risk across development and manufacturing.
05

REGULATORY & QUALITY

IND/CTA → NDA/BLA/MAA
Governance Coverage
Regulatory Strategy CMC Documentation Quality Oversight Audits Data Integrity Inspection Readiness
Vendor-neutral review helps ensure that outsourced activities remain aligned with program, quality and regulatory expectations.
06

COMMERCIAL & LIFECYCLE

Approval → Supply → Lifecycle
Governance Coverage
PPQ CPV Site Transfers Second Source Supply Continuity Lifecycle Strategy
Aventiq supports technical decision-making as programs transition from development into commercial supply.

The Strategic Reality

Most global pharma and biotech programs lose 9–18 months and USD 5–25 million when navigating India without continuous, on-ground oversight.

The result is often a cascade: Form 483 → Warning Letter → Import Alert → Program Termination.
The Aventiq Governance Framework™ was built to prevent this outcome.

The causes are predictable:

Vendor selection based on paper audits

Technical drift during tech transfer

Data integrity gaps discovered too late

"Audit-only" compliance with no lifecycle ownership

Why Choose Us?

The Five Pillars of Technical Stewardship

A governance model designed to de-risk high-complexity programs

+ Read More

Our 4-step system for Predictable Success

A system designed to deliver repeatable outcomes

+ Read More

What the Aventiq Governance Framework™

A structured, five-pillar governance model, reinforced by AI-enabled intelligence and continuous human oversight, designed to de-risk high-complexity programs including:

 
NCEs & complex generics
Biologics & biosimilars
ADCs, HPAPIs, and conjugated therapeutics
Cell & Gene Therapy
Vaccines and precision medicine programs
 

Ready to Secure Your Pipeline?

High-stakes programs require more than audits.They require continuous governance.

Book A Strategy Call
All engagements are confidential. No information is shared without written consent.
×

Search

Press Enter to search